Imax CORP Form 4 insider transactions

Robert D Lister, Chief Legal Officer Sr Exec VP of Imax Corp, sold 22,500 shares of common stock on September 10, 2026 for $51.58 per share.

Mark Welton, President IMAX Global Theatres of Imax Corp, sold 30,000 shares of common stock on August 25, 2026 for $54.47 per share.

Kenneth Ian Weissman, Deputy GC, Corp. Sec. & CCO of Imax Corp, sold 8,000 shares of common stock on August 25, 2026 for $54.54 per share.

Calamera Pablo, CTO & EVP of Imax Corp, sold 15,000 shares of common stock on August 20, 2026 for $52.41 per share.

Richard L Gelfond, Chief Executive Officer and a Director of Imax Corp, sold 456,757 shares of common stock on August 18, 2026.

IMAX Corp director Darren Throop reported transactions involving common shares and restricted share units on June 11, 2026.

IMAX Corp Director Michael MacMillan reported transactions involving common shares and restricted share units on June 11, 2026.

IMAX Corp director Dana R. Settle has reported the acquisition of 3,390 common shares through the vesting of restricted share units.

IMAX Corporation Director Jennifer L. Wong reported a transaction involving the acquisition of 3,390 common shares upon the vesting of restricted share units.

IMAX Corporation Director Steve Pamon reported transactions involving restricted share units converting to common shares.

IMAX Corporation Director Gail Berman acquired 3,390 common shares through the vesting of restricted share units.

IMAX Corporation director David W. Leebron has reported the acquisition of 3,390 common shares through the vesting of restricted share units.

IMAX Corp reports a Form 4 filing detailing a transaction by Director Kevin Douglas, who acquired 3,390 shares of common stock.

IMAX CEO Richard Gelfond exercised stock options and sold the resulting common shares under a pre-arranged 10b5-1 trading plan.

IMAX CEO Richard Gelfond exercised and sold 120,132 shares of common stock under a pre-arranged 10b5-1 trading plan.

IMAX CEO Richard Gelfond reported transactions involving company stock, including the exercise of stock options and the sale of common shares.

IMAX CEO Richard Gelfond executed transactions involving the purchase and sale of company shares under a pre-arranged 10b5-1 trading plan.

IMAX Corporation's CEO of IMAX China Holding, Inc., Daniel Manwaring, has filed an amendment to a previous Form 4, correcting details regarding the withholding of shares for tax purposes and updating his beneficial ownership.

IMAX Director and 10% owner Kevin Douglas, along with related entities, plans to sell 568,000 shares of common stock for approximately $21.5 million on March 16, 2026, under a 10b5-1 plan.

IMAX CEO Richard L. Gelfond exercised stock options and immediately sold the resulting common shares as part of a pre-arranged 10b5-1 trading plan.

IMAX CEO Richard L. Gelfond reported the conversion of restricted share units into common shares and subsequent tax-related share disposals, resulting in a net increase in his direct common share holdings to 635,940.

IMAX Global Theatres President Mark Welton sold 25,000 common shares for $39.28 each, as part of a pre-arranged 10b5-1 trading plan.

IMAX Chief Legal Officer Robert D. Lister gifted 2,000 common shares to a donor-advised fund, citing upcoming changes in tax regulations for charitable donations.

IMAX Chief Financial Officer Natasha Fernandes exercised stock options and subsequently sold an equal number of common shares on November 24, 2025.

IMAX CEO Richard L. Gelfond gifted 40,000 common shares to a donor-advised fund, citing upcoming changes in tax regulations.

IMAX Global Theatres President Mark Welton exercised stock options and subsequently sold the acquired common shares on November 10, 2025.

IMAX Chief Commercial Officer Giovanni M. Dolci exercised stock options and subsequently sold the acquired common shares on November 10, 2025, as part of a pre-arranged 10b5-1 plan.

IMAX Corporation's CTO and EVP, Pablo Calamera, sold 20,586 common shares for approximately $704,500 on November 10, 2025.

IMAX's Chief Legal Officer, Robert D. Lister, exercised stock options and subsequently sold 50,143 common shares on November 7, 2025, under a 10b5-1 plan.

IMAX Chief Legal Officer Robert D. Lister sold 20,000 common shares for $32.80 each, executing a pre-arranged 10b5-1 trading plan.